Literature DB >> 27664588

Influence of glucagon-like peptide 2 on energy homeostasis.

Sara Baldassano1, Antonella Amato1, Flavia Mulè2.   

Abstract

Glucagon like peptide-2 (GLP-2) is a gastrointestinal hormone released from enteroendocrine L-type cells together with glucagon like peptide-1 in response to dietary nutrients. GLP-2 acts through a specific receptor, the GLP-2 receptor, mainly located in the gut and in the brain. Classically, GLP-2 is considered a trophic hormone involved in the maintenance of intestinal epithelial morphology and function. This role has been targeted for therapies promoting repair and adaptive growth of the intestinal mucosa. Recently, GLP-2 has been shown to exert beneficial effects on glucose metabolism specially in conditions related to increased uptake of energy, such as obesity. Several actions of GLP-2 are related to a positive energy balance: GLP-2 increases not only the absorptive surface, but also expression and activity of epithelial brush-border nutrient transporters and digestive enzymes, intestinal blood flow, postprandial chylomicron secretion and it inhibits gastrointestinal motility, providing the opportunity to increase absorption of nutrients. Other actions, including anorexigenic effects, appear in opposition to the energy intake. In this review, we discuss the GLP-2 functions related to energy homeostasis. GLP-2 could be considered an hormone causing positive energy balance, which, however has the role to mitigate the metabolic dysfunctions associated with hyper-adiposity. Copyright Â
© 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Food intake; GLP-2; Insulin resistance; L-type enteroendocrine cells; Obesity

Mesh:

Substances:

Year:  2016        PMID: 27664588     DOI: 10.1016/j.peptides.2016.09.010

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  12 in total

1.  The effect of body mass index on glucagon-like peptide receptor gene expression in the post mortem brain from individuals with mood and psychotic disorders.

Authors:  Rodrigo B Mansur; Gabriel R Fries; Alisson P Trevizol; Mehala Subramaniapillai; Julie Lovshin; Kangguang Lin; Maj Vinberg; Roger C Ho; Elisa Brietzke; Roger S McIntyre
Journal:  Eur Neuropsychopharmacol       Date:  2018-11-06       Impact factor: 4.600

2.  Adropin and glucagon-like peptide-2 are associated with glucose metabolism in obese children.

Authors:  Rui-Min Chen; Xin Yuan; Qian Ouyang; Xiang-Quan Lin; Zhuan-Zhuan Ai; Ying Zhang; Xiao-Hong Yang
Journal:  World J Pediatr       Date:  2019-10-10       Impact factor: 2.764

3.  A Three-Day Intervention With Granola Containing Cereal Beta-Glucan Improves Glycemic Response and Changes the Gut Microbiota in Healthy Individuals: A Crossover Study.

Authors:  Vibeke H Telle-Hansen; Line Gaundal; Benedicte Høgvard; Stine M Ulven; Kirsten B Holven; Marte G Byfuglien; Ingrid Måge; Svein Halvor Knutsen; Simon Ballance; Anne Rieder; Ida Rud; Mari C W Myhrstad
Journal:  Front Nutr       Date:  2022-04-28

4.  Dietary supplementation of artificial sweetener and capsicum oleoresin as a strategy to mitigate the negative consequences of heat stress on pig performance.

Authors:  Morgan E Biggs; Kellie A Kroscher; Lidan D Zhao; Zhenhe Zhang; Emma H Wall; David M Bravo; Robert P Rhoads
Journal:  J Anim Sci       Date:  2020-05-01       Impact factor: 3.159

5.  Glucagon-like peptide-2 modulates the nitrergic neurotransmission in strips from the mouse gastric fundus.

Authors:  Rachele Garella; Eglantina Idrizaj; Chiara Traini; Roberta Squecco; Maria Giuliana Vannucchi; Maria Caterina Baccari
Journal:  World J Gastroenterol       Date:  2017-10-28       Impact factor: 5.742

Review 6.  Bile Acid Signaling Pathways from the Enterohepatic Circulation to the Central Nervous System.

Authors:  Kim L Mertens; Andries Kalsbeek; Maarten R Soeters; Hannah M Eggink
Journal:  Front Neurosci       Date:  2017-11-07       Impact factor: 4.677

7.  Increased Body Weight and Fat Mass After Subchronic GIP Receptor Antagonist, but Not GLP-2 Receptor Antagonist, Administration in Rats.

Authors:  Sara Baldassano; Lærke Smidt Gasbjerg; Hüsün Sheyma Kizilkaya; Mette Marie Rosenkilde; Jens Juul Holst; Bolette Hartmann
Journal:  Front Endocrinol (Lausanne)       Date:  2019-08-06       Impact factor: 5.555

8.  Consumption of a Natural High-Intensity Sweetener Enhances Activity and Expression of Rabbit Intestinal Na+/Glucose Cotransporter 1 (SGLT1) and Improves Colibacillosis-Induced Enteric Disorders.

Authors:  Andrew W Moran; Miran A Al-Rammahi; Kristian Daly; Emeline Grand; Catherine Ionescu; David M Bravo; Emma H Wall; Soraya P Shirazi-Beechey
Journal:  J Agric Food Chem       Date:  2019-12-17       Impact factor: 5.279

9.  A unique hormonal recognition feature of the human glucagon-like peptide-2 receptor.

Authors:  Wen Sun; Li-Nan Chen; Qingtong Zhou; Li-Hua Zhao; Dehua Yang; Huibing Zhang; Zhaotong Cong; Dan-Dan Shen; Fenghui Zhao; Fulai Zhou; Xiaoqing Cai; Yan Chen; Yan Zhou; Sarina Gadgaard; Wijnand J C van der Velden; Suwen Zhao; Yi Jiang; Mette M Rosenkilde; H Eric Xu; Yan Zhang; Ming-Wei Wang
Journal:  Cell Res       Date:  2020-11-25       Impact factor: 25.617

10.  GLP-2 Prevents Neuronal and Glial Changes in the Distal Colon of Mice Chronically Treated with Cisplatin.

Authors:  Patrizia Nardini; Alessandro Pini; Anne Bessard; Emilie Duchalais; Elena Niccolai; Michel Neunlist; Maria Giuliana Vannucchi
Journal:  Int J Mol Sci       Date:  2020-11-23       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.